These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 28342735)
1. Inhibition of effector antigen-specific T cells by intradermal administration of heme oxygenase-1 inducers. Simon T; Pogu J; Rémy S; Brau F; Pogu S; Maquigneau M; Fonteneau JF; Poirier N; Vanhove B; Blancho G; Piaggio E; Anegon I; Blancou P J Autoimmun; 2017 Jul; 81():44-55. PubMed ID: 28342735 [TBL] [Abstract][Full Text] [Related]
2. Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4(+) T cells specific for both a myelin and a neuronal self-antigen in mice. Lucca LE; Axisa PP; Aloulou M; Perals C; Ramadan A; Rufas P; Kyewski B; Derbinski J; Fazilleau N; Mars LT; Liblau RS Eur J Immunol; 2016 Sep; 46(9):2247-59. PubMed ID: 27334749 [TBL] [Abstract][Full Text] [Related]
3. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis. Zheng H; Zhang H; Liu F; Qi Y; Jiang H Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208 [TBL] [Abstract][Full Text] [Related]
4. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance. Zheng P; Fu H; Wei G; Wei Z; Zhang J; Ma X; Rui D; Meng X; Ming L Clin Immunol; 2016 Aug; 169():36-46. PubMed ID: 27327113 [TBL] [Abstract][Full Text] [Related]
5. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. Chora AA; Fontoura P; Cunha A; Pais TF; Cardoso S; Ho PP; Lee LY; Sobel RA; Steinman L; Soares MP J Clin Invest; 2007 Feb; 117(2):438-47. PubMed ID: 17256058 [TBL] [Abstract][Full Text] [Related]
6. Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells. Listopad J; Asadullah K; Sievers C; Ritter T; Meisel C; Sabat R; Döcke WD Exp Dermatol; 2007 Aug; 16(8):661-70. PubMed ID: 17620093 [TBL] [Abstract][Full Text] [Related]
7. Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials. Krishnamurthy B; Selck C; Chee J; Jhala G; Kay TW J Autoimmun; 2016 Jul; 71():35-43. PubMed ID: 27083395 [TBL] [Abstract][Full Text] [Related]
8. De novo-induced self-antigen-specific Foxp3+ regulatory T cells impair the accumulation of inflammatory dendritic cells in draining lymph nodes. Alissafi T; Hatzioannou A; Ioannou M; Sparwasser T; Grün JR; Grützkau A; Verginis P J Immunol; 2015 Jun; 194(12):5812-24. PubMed ID: 25948818 [TBL] [Abstract][Full Text] [Related]
9. Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα. Nuro-Gyina PK; Rieser EL; Granitto MC; Pei W; Liu Y; Lee PW; Aqel S; Zhang J; Lovett-Racke AE; Racke MK; Yang Y J Neuroinflammation; 2016 Dec; 13(1):302. PubMed ID: 27912762 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy. Schillingmann DA; Riese SB; Vijayan V; Tischer-Zimmermann S; Schmetzer H; Maecker-Kolhoff B; Blasczyk R; Immenschuh S; Eiz-Vesper B Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678050 [TBL] [Abstract][Full Text] [Related]
11. Heme oxygenase (HO-1) is involved in the negative regulation of contact sensitivity reaction. Majewska M; Zajac K; Dulak J; Szczepanik M Pharmacol Rep; 2008; 60(6):933-40. PubMed ID: 19211986 [TBL] [Abstract][Full Text] [Related]
12. Micro-RNA-155-mediated control of heme oxygenase 1 (HO-1) is required for restoring adaptively tolerant CD4+ T-cell function in rodents. Zhang J; Vandevenne P; Hamdi H; Van Puyvelde M; Zucchi A; Bettonville M; Weatherly K; Braun MY Eur J Immunol; 2015 Mar; 45(3):829-42. PubMed ID: 25641586 [TBL] [Abstract][Full Text] [Related]
13. Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells. Tardif V; Riquelme SA; Remy S; Carreño LJ; Cortés CM; Simon T; Hill M; Louvet C; Riedel CA; Blancou P; Bach JM; Chauveau C; Bueno SM; Anegon I; Kalergis AM Eur J Immunol; 2013 Nov; 43(11):2832-44. PubMed ID: 23852701 [TBL] [Abstract][Full Text] [Related]
14. Effector T cell differentiation in experimental interstitial nephritis. I. The development and modulation of effector lymphocyte maturation by I-J+ regulatory T cells. Mann R; Kelly CJ; Hines WH; Clayman MD; Blanchard N; Sun MJ; Neilson EG J Immunol; 1987 Jun; 138(12):4200-8. PubMed ID: 2953801 [TBL] [Abstract][Full Text] [Related]
15. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells. Matsushima GK; Stohlman SA J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982 [TBL] [Abstract][Full Text] [Related]
16. IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development. Kavrochorianou N; Evangelidou M; Markogiannaki M; Tovey M; Thyphronitis G; Haralambous S J Leukoc Biol; 2016 Jan; 99(1):175-88. PubMed ID: 26232452 [TBL] [Abstract][Full Text] [Related]
17. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen. Laliotou B; Duncan L; Dick AD J Autoimmun; 1999 May; 12(3):145-55. PubMed ID: 10222024 [TBL] [Abstract][Full Text] [Related]
18. A new T-cell activation mode for suboptimal doses of antigen under the full activation of T cells with different specificity. Shibuya M; Fujio K; Shoda H; Okamura T; Okamoto A; Sumitomo S; Yamamoto K Eur J Immunol; 2015 Jun; 45(6):1643-53. PubMed ID: 25789709 [TBL] [Abstract][Full Text] [Related]
19. Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells. Xiao J; Yang R; Yang L; Fan X; Liu W; Deng W Sci Rep; 2015 Mar; 5():9022. PubMed ID: 25762107 [TBL] [Abstract][Full Text] [Related]
20. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Matheu MP; Beeton C; Garcia A; Chi V; Rangaraju S; Safrina O; Monaghan K; Uemura MI; Li D; Pal S; de la Maza LM; Monuki E; Flügel A; Pennington MW; Parker I; Chandy KG; Cahalan MD Immunity; 2008 Oct; 29(4):602-14. PubMed ID: 18835197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]